Psychiatry and Neurology, Neurology · Newport News, VA
NPI
1316966328
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12200 Warwick Blvd, Ste 110
Newport News, VA, 23601
Phone (757) 534-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
6,818 services
Medicare patients, 2024
707
Average age 74
Drug cost, 2024
$840K
4,521 prescriptions
Company payments, 2025
$454
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamel Ben-Othmane was code 99214 (office e&m - established), 234 times for 165 patients. In total Kamel Ben-Othmane billed 6,818 services in 42 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 234 | 165 | $67.98 | $16K |
| 64615 Musculoskeletal | Facility | 225 | 71 | $85.85 | $19K |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 165 | 164 | $26.40 | $4,356 |
| 64405 Musculoskeletal | Facility | 120 | 36 | $51.29 | $6,155 |
| 95816 Neurologic | Facility | 111 | 107 | $39.88 | $4,427 |
| 95885 Electrical Nerve Conductivity | Facility | 107 | 74 | $14.18 | $1,517 |
| 76882 Ultrasound - Nonspecific | Facility | 105 | 71 | $24.68 | $2,591 |
| 99213 Office E&M - Established | Facility | 82 | 63 | $47.39 | $3,886 |
| 95886 Electrical Nerve Conductivity | Facility | 82 | 71 | $32.99 | $2,705 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 53 | $12.03 | $661 |
| 64400 Musculoskeletal | Facility | 50 | 12 | $41.05 | $2,053 |
| 95910 Electrical Nerve Conductivity | Facility | 41 | 41 | $75.74 | $3,105 |
| 95913 Electrical Nerve Conductivity | Facility | 36 | 36 | $140.25 | $5,049 |
| 95911 Electrical Nerve Conductivity | Facility | 26 | 26 | $95.95 | $2,495 |
| 95909 Electrical Nerve Conductivity | Facility | 26 | 26 | $54.20 | $1,409 |
By year: 2022 $89K for 5,252 services; 2023 $85K for 5,282 services; 2024 $92K for 6,818 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kamel Ben-Othmane prescribed most often to Medicare patients was Gabapentin, with 319 prescriptions and refills. In total Kamel Ben-Othmane wrote 4,521 Medicare prescriptions that cost $840K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 319 | 485 | 78 | $5,316 |
| Aimovig Autoinjector Erenumab-Aooe | 235 | 269 | 37 | $192K |
| Topiramate Generic | 235 | 420 | 61 | $2,552 |
| Sumatriptan Succinate Generic | 213 | 243 | 52 | $5,090 |
| Amitriptyline Hcl Generic | 209 | 325 | 49 | $2,247 |
| Memantine Hcl Generic | 198 | 326 | 43 | $3,799 |
| Levetiracetam Generic | 149 | 315 | 41 | $4,143 |
| Propranolol Hcl Er Propranolol Hcl | 143 | 220 | 34 | $4,102 |
| Lacosamide Generic | 132 | 146 | 17 | $12K |
| Lamotrigine Generic | 125 | 203 | 21 | $2,009 |
| Divalproex Sodium Generic | 118 | 223 | 33 | $3,593 |
| Rizatriptan Rizatriptan Benzoate | 101 | 124 | 28 | $2,464 |
| Duloxetine Hcl Generic | 99 | 148 | 19 | $1,427 |
| Donepezil Hcl Generic | 89 | 192 | 26 | $399 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 87 | 87 | 21 | $875 |
Brand drugs: 604 claims; generic drugs: 3,894 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamel Ben-Othmane $454 ($454 in general payments such as food, travel and fees) from 6 companies. The largest payer was Ceribell, Inc. with $184.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.